MAURICE J. SMALL, M.D., F.A.C.P.
In a discussion of the modern medical treatment of tuberculosis it should be pointed out at the start that this treatment is still very young and that there are still many unanswered problems which are being actively investigated. Streptomycin (SM) did not come into general use until late 1947, para-aminosalicylic acid (PAS) in 1949, and iso-nicotinic acid hydrazide (INH) in 1952, and the concept of long-term chemotherapy with these drugs is quite new and its final evaluation far from complete. This discussion will therefore attempt to summarize what is currently accepted by the best authorities in the medical treatment of
SMALL MJ. THE MODERN MEDICAL TREATMENT OF PULMONARY TUBERCULOSIS*. Ann Intern Med. 1955;43:539–548. doi: https://doi.org/10.7326/0003-4819-43-3-539
Download citation file:
Published: Ann Intern Med. 1955;43(3):539-548.
Infectious Disease, Mycobacterial Infections, Pulmonary Tuberculosis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use